Stock Pick

Author: therawinformant

  • Inovio’s Drug For Rare Respiratory Tract Disorder Granted Orphan Designation

    Inovio's Drug For Rare Respiratory Tract Disorder Granted Orphan DesignationInovio Pharmaceuticals Inc (NASDAQ: INO) shares were volatile Wednesday after the company announced Orphan Drug Designation for one of its pipeline drugs.What Happened: The Plymouth, Pennsylvania-based company said the FDA granted ODD for INO-3107, a DNA medicine that's being evaluated in a Phase 1/2 trial for treatment of recurrent respiratory papillomatosis, or RRP.RRP is a rare disease caused by human papillomavirus types 6 and 11 infections that causes non-cancerous tumor growths leading to life-threatening airway obstructions, the company said.Why It's Important: The ODD from the FDA qualifies INO-3107 for various development incentives, including a tax credit on expenditures incurred in clinical studies; a waiver of the new drug application fee; a research grant awarded by the FDA; and most importantly, seven years of U.S. market exclusivity upon approval for the treatment of RRP, Inovio said."Receiving FDA's orphan drug designation for INO-3107 is an important milestone in the development of Inovio's DNA medicine for this rare disease and clearly underscores the importance of addressing the unmet medical need for this debilitating condition," Ami Shah Brown, Inovio's senior vice president fo regulatory affairs, said in a statement.Inovio is developing a DNA vaccine for SARS-CoV2, the virus that causes COVID-19. The vaccine program is embroiled in litigation with its CDMO partner, as well as a shareholder lawsuit accusing the company of stock pumping.The company is scheduled to report second-quarter results Monday, Aug. 10.INO Price Action: At last check, Inovio shares were sliding 4.23% to $19.91.Related Links: The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings Inovio Analyst Downgrades COVID-19 Vaccine Developer, Says Risk Higher After Rally See more from Benzinga * Inovio Subcontractor Hits Back With Lawsuit Against Coronavirus Vaccine Developer * The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/3gcNQj8

  • Kodak CEO on federal deal: ‘We’re more of a chemical company’ than a camera brand

    Kodak CEO on federal deal: 'We're more of a chemical company' than a camera brandKodak's stock skyrocketed by over 500% in intraday trading, taking Wall Street by surprise after mostly flatlining in recent years.

    from Yahoo Finance https://ift.tt/3hMgnfL

  • Column: In GOP plan, you can’t sue your employers for giving you COVID — but they can sue you

    Column: In GOP plan, you can't sue your employers for giving you COVID — but they can sue youThe Republican proposal on coronavirus relief puts all the risk from catching COVID-19 on workers.

    from Yahoo Finance https://ift.tt/3f6uCKF

  • Federal Reserve holds rates steady at near-zero

    Federal Reserve holds rates steady at near-zeroThe Federal Reserve on Wednesday maintained interest rates at near-zero, noting that economic activity and employment have “picked up somewhat in recent months” but cautioning that the virus needs to be contained. Yahoo Finance’s Brian Cheung joins Akiko Fujita to discuss.

    from Yahoo Finance https://ift.tt/3hSbLVH

  • Amazon, Apple, Facebook, and Google CEOs push America-first narrative in effort to avoid antitrust scrutiny

    Amazon, Apple, Facebook, and Google CEOs push America-first narrative in effort to avoid antitrust scrutinyTech CEOs push America-first narrative in antitrust hearing to sway lawmakers.

    from Yahoo Finance https://ift.tt/338sZtU

  • Kosmos Energy Ltd. (NYSE:KOS) Is Expected To Breakeven

    Kosmos Energy Ltd. (NYSE:KOS) Is Expected To BreakevenKosmos Energy Ltd.'s (NYSE:KOS): Kosmos Energy Ltd., a deepwater independent oil and gas exploration and production…

    from Yahoo Finance https://ift.tt/3f5ysDW

  • New IPO Azek In Buy Zone

    from Yahoo Finance https://ift.tt/39IiLl1

  • Dems believed they had a strong negotiation position with the federal $600: Fmr. Assistant Treasury Secretary on stimulus

    Dems believed they had a strong negotiation position with the federal $600: Fmr. Assistant Treasury Secretary on stimulus Chris Campbell, Chief Strategist at Duff & Phelps Institute and Former Assistant Secretary of the Treasury for Financial Institutions joins Yahoo Finance’s On The Move to break down the Fed’s economic outlook amid the coronavirus crisis.

    from Yahoo Finance https://ift.tt/3gda98p

  • Elon Musk Confirms Cybertruck Can Come in Multiple Colors

    Elon Musk Confirms Cybertruck Can Come in Multiple ColorsAs construction starts on the Tesla Inc (NASDAQ: TSLA) Gigafactory in Austin, Texas, Tesla fans are looking forward to receiving their Tesla Cybertruck. A new tweet from CEO Elon Musk confirms the truck's cold-rolled stainless steel can be given various colors with a simple heat treatment.Responding to a fan asking if Cybertruck's steel can be tempered, Musk simply responded "Yes." Stainless steel can be tempered many different shades, depending on the temperature used. This would give a permanent look to the metallic surface> Different colors the CyberTruck can be tempered: pic.twitter.com/GQnyHTCRlC> > — K10✨(C)️ (@Kristennetten) July 26, 2020Benzinga's Take: This is great news for fans that weren't initially impressed with Cybertruck's looks. The stainless steel look was quite controversial at the reveal, and the lack of paint took away one of the main customization options on a vehicle. Many fans also are looking forward to putting a custom wrap on their Cybertruck, which is an option Musk endorsed back in April.See more from Benzinga * Tesla's Battery Production In Germany Will Bring 'Completely New Batteries': Report * Hundreds Of Tesla Model 3s Arrive in Hong Kong For Delivery: Report(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/335bwCl

  • Boeing to cease 747 production as losses hit $2.4bn

    Boeing to cease 747 production as losses hit $2.4bnThe US planemaker has also warned of job cuts beyond the 10% reduction already announced.

    from Yahoo Finance https://ift.tt/30WtyEh